MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

Wang,Tairen; Li,Fei; Tang,Shengjian

doi:10.3892/ol.2014.2723

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

Authors:
- Tairen Wang
- Fei Li
- Shengjian Tang
View Affiliations

Affiliations: Institute of Plastic Surgery, Weifang Medical College, Weifang, Shandong 261041, P.R. China
Published online on: November 20, 2014 https://doi.org/10.3892/ol.2014.2723
Pages: 967-971

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

FOXL2 is a transcription factor that is essential for ovarian development. Somatic mutations of FOXL2 are associated with ovarian granulosa cell tumorigenesis. In the present study, the expression of FOXL2 was suppressed by microRNAs using the Ago2 knockdown method in COV434 cells. Online bioinformatics tools were utilized to predict that FOXL2 expression may be repressed by miR‑30 family members, and dual luciferase assay and western blotting were performed to demonstrate that FOXL2 is a target gene of miR‑30a, which is relatively abundant in COV434 cells. Furthermore, miR‑30a overexpression upregulates BCL2A1, IER3 and cyclin D2 expression by inhibiting FOXL2. miR‑30a is known to function as a tumor suppressor in breast cancer, small cell lung cancer and colorectal carcinoma; however, the present study revealed an opposing function of miR‑30a as an oncogene.

View Figures

View References

1	Crisponi L, Uda M, Deiana M, et al: FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences. Genomics. 83:757–764. 2004. View Article : Google Scholar : PubMed/NCBI
2	De Baere E, Beysen D, Oley C, et al: FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet. 72:478–487. 2003. View Article : Google Scholar : PubMed/NCBI
3	De Baere E, Dixon MJ, Small KW, et al: Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype - phenotype correlation. Hum Mol Genet. 10:1591–1600. 2001. View Article : Google Scholar : PubMed/NCBI
4	Zlotogora J, Sagi M and Cohen T: The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet. 35:1020–1027. 1983.PubMed/NCBI
5	Benayoun BA, Batista F, Auer J, et al: Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations. Hum Mol Genet. 18:632–644. 2009. View Article : Google Scholar
6	Pisarska MD, Kuo FT, Bentsi-Barnes IK, Khan S and Barlow GM: LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity. Am J Physiol Endocrinol Metab. 299:E101–E109. 2010. View Article : Google Scholar : PubMed/NCBI
7	Pisarska MD, Barlow G and Kuo FT: Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology. Endocrinology. 152:1199–1208. 2011. View Article : Google Scholar : PubMed/NCBI
8	Benayoun BA, Anttonen M, L’Hôte D, et al: Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p. Cys134Trp somatic mutation. Oncogene. 32:2739–2746. 2013. View Article : Google Scholar
9	Maes OC, Chertkow HM, Wang E and Schipper HM: MicroRNA: Implications for Alzheimer disease and other human CNS disorders. Curr Genomics. 10:154–168. 2009. View Article : Google Scholar : PubMed/NCBI
10	Xu J, Li Y, Wang F, et al: Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene. 32:976–987. 2013. View Article : Google Scholar
11	Farazi TA, Hoell JI, Morozov P and Tuschl T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013. View Article : Google Scholar : PubMed/NCBI
12	Friedman RC, Farh KK, Burge CB and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:92–105. 2009. View Article : Google Scholar :
13	Lee H, Park CS, Deftereos G, et al: MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. World J Surg Oncol. 10:1742012. View Article : Google Scholar : PubMed/NCBI
14	Corrêa FJ, Tavares AB, Pereira RW and Abrão MS: A new FOXL2 gene mutation in a woman with premature ovarian failure and sporadic blepharophimosis-ptosis-epicanthus inversus syndrome. Fertil Steril. 93:e3–e6. 2010.
15	Kim JH, Yoon S, Park M, et al: Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W). Oncogene. 30:1653–1663. 2011. View Article : Google Scholar
16	Kalfa N, Fellous M, Boizet-Bonhoure B, et al: Aberrant expression of ovary determining gene FOXL2 in the testis and juvenile granulosa cell tumor in children. J Urol. 180:1810–1813. 2008. View Article : Google Scholar : PubMed/NCBI
17	Kalfa N, Philibert P, Patte C, et al: Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril. 87:896–901. 2007. View Article : Google Scholar : PubMed/NCBI
18	D’Sa-Eipper C and Chinnadurai G: Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene. 16:3105–3114. 1998. View Article : Google Scholar
19	Wu MX, Ao Z, Prasad KV, Wu R and Schlossman SF: IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science. 281:998–1001. 1998. View Article : Google Scholar : PubMed/NCBI
20	Bentsi-Barnes IK, Kuo FT, Barlow GM and Pisarska MD: Human forkhead L2 represses key genes in granulosa cell differentiation including aromatase, P450scc, and cyclin D2. Fertil Steril. 94:353–356. 2010. View Article : Google Scholar :
21	Zhang N, Wang X, Huo Q, et al: MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene. 33:3119–3128. 2014. View Article : Google Scholar
22	Jiang BY, Zhang XC, Su J, et al: BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification. Mol Cancer. 12:612013. View Article : Google Scholar : PubMed/NCBI
23	Zhong M, Bian Z and Wu Z: miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. Cell Physiol Biochem. 31:209–218. 2013. View Article : Google Scholar : PubMed/NCBI